JP2012127879A5 - Method of determining the degree of progression of nephropathy and agent for suppressing fibrosis - Google Patents

Method of determining the degree of progression of nephropathy and agent for suppressing fibrosis Download PDF

Info

Publication number
JP2012127879A5
JP2012127879A5 JP2010281080A JP2010281080A JP2012127879A5 JP 2012127879 A5 JP2012127879 A5 JP 2012127879A5 JP 2010281080 A JP2010281080 A JP 2010281080A JP 2010281080 A JP2010281080 A JP 2010281080A JP 2012127879 A5 JP2012127879 A5 JP 2012127879A5
Authority
JP
Japan
Prior art keywords
nephropathy
progression
agent
determining
degree
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010281080A
Other languages
Japanese (ja)
Other versions
JP2012127879A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2010281080A priority Critical patent/JP2012127879A/en
Priority claimed from JP2010281080A external-priority patent/JP2012127879A/en
Publication of JP2012127879A publication Critical patent/JP2012127879A/en
Publication of JP2012127879A5 publication Critical patent/JP2012127879A5/en
Pending legal-status Critical Current

Links

JP2010281080A 2010-12-16 2010-12-16 Method for determining progress of nephropathy, and fibrillation inhibitor Pending JP2012127879A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010281080A JP2012127879A (en) 2010-12-16 2010-12-16 Method for determining progress of nephropathy, and fibrillation inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010281080A JP2012127879A (en) 2010-12-16 2010-12-16 Method for determining progress of nephropathy, and fibrillation inhibitor

Publications (2)

Publication Number Publication Date
JP2012127879A JP2012127879A (en) 2012-07-05
JP2012127879A5 true JP2012127879A5 (en) 2014-01-23

Family

ID=46645073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010281080A Pending JP2012127879A (en) 2010-12-16 2010-12-16 Method for determining progress of nephropathy, and fibrillation inhibitor

Country Status (1)

Country Link
JP (1) JP2012127879A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6601707B2 (en) * 2015-02-15 2019-11-06 国立大学法人金沢大学 Fibrosis determination method
JP7126668B2 (en) * 2017-08-09 2022-08-29 国立大学法人金沢大学 Collagen disease determination method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4381495B2 (en) * 1998-10-30 2009-12-09 株式会社三和化学研究所 MCP-1 receptor antagonist comprising organic germanium compound as active ingredient, and preventive or therapeutic agent for inflammatory disease and organ disorder involving MCP-1
JP2000229856A (en) * 1999-02-08 2000-08-22 Sanwa Kagaku Kenkyusho Co Ltd Prophylactic or therapeutic agent for onset of arteriosclerotic disease containing organogermanium compound as active ingredient
JP2003081843A (en) * 2001-09-10 2003-03-19 Sanwa Kagaku Kenkyusho Co Ltd Agent for critical prevention and treatment of type ii diabetic nephropathy containing organogermanium compound as active ingredient
WO2006029173A2 (en) * 2004-09-08 2006-03-16 Boys Town National Research Hospital Treatment of glomerular basement membrane disease involving matrix metalloproteinase-12
WO2008067559A2 (en) * 2006-11-30 2008-06-05 University Of Virginia Patent Foundation Methods for treating and diagnosing fibrotic and fibroproliferative diseases
JP2008303191A (en) * 2007-06-11 2008-12-18 Kyoto Univ Preventing or ameliorating agent for disease relating to dysfunction of fat cell containing organic germanium compound as active component

Similar Documents

Publication Publication Date Title
EP2670866A4 (en) Biomarkers and methods of use thereof
EP2619184A4 (en) Deubiquitinase inhibitors and methods for use of the same
BR112012017441A2 (en) compounds and methods
BR112013016969A2 (en) apparatus and method
CO6821917A2 (en) Building block and construction method of said block
BR112013012059A2 (en) systems and methods for unoptimized handoff
IL232598A0 (en) Solid state forms of vilazodone and vilazodone hydrochloride
BR112012027159A2 (en) structure and method
BR112012028015A2 (en) apparatus and method
BR112014010450A2 (en) composition and method
BR112013011096A2 (en) relay node and reconnect method
FI20115463A (en) Brake and method of making the brake
BR112012012798A2 (en) codec and terminal capacity negotiation method
BR112013003535A2 (en) foaming method
BR112013008982A2 (en) apparatus including metal foam and methods for using the same downhole
BR112013005471A2 (en) abrasive brush and method
DK2661274T3 (en) COMPOSITIONS AND METHODS OF ALOEPOLYSACCHARIDES
BR112014010860A2 (en) composition and method
GB201011275D0 (en) Support platform and method of construction thereof
IL225767A0 (en) Method of determining cleanliness
PT2593127T (en) Anti-angiogenic agent and method of using such agent
JP2012127879A5 (en) Method of determining the degree of progression of nephropathy and agent for suppressing fibrosis
BR112013008812A2 (en) composition and method
BR112012029669A2 (en) composition and method
FI20105730A0 (en) METHOD FOR MANUFACTURE OF THE C-PRESSURE BODY, C-PRESSURE BODY AND C-PRESSURE